Bank of America
ELOX

Bank of America’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Bank of America’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-371
Closed -$931 – 8214
2023
Q1 		$931 Sell
371
-1,578
-81% -$5.71K ﹤0.01% 7315
2022
Q4 		$3.55K Buy
1,949
+498
+34% +$2.4K ﹤0.01% 7124
2022
Q3 		$10K Sell
1,451
-1
-0.1% -$12 ﹤0.01% 7252
2022
Q2 		$16K Sell
1,452
-3
-0.2% -$41 ﹤0.01% 7259
2022
Q1 		$32K Buy
1,455
+1,024
+238% +$20.1K ﹤0.01% 7349
2021
Q4 		$12K Buy
431
+279
+184% +$12.2K ﹤0.01% 7673
2021
Q3 		$9K Buy
152
+129
+561% +$7.95K ﹤0.01% 7612
2021
Q2 		$2K Sell
23
-919
-98% -$76.7K ﹤0.01% 7572
2021
Q1 		$125K Buy
942
+689
+272% +$105K ﹤0.01% 6299
2020
Q4 		$40K Buy
253
+122
+93% +$14.9K ﹤0.01% 6406
2020
Q3 		$14K Sell
131
-71
-35% -$8.51K ﹤0.01% 6372
2020
Q2 		$24K Buy
202
+50
+33% +$5.66K ﹤0.01% 6226
2020
Q1 		$12K Sell
152
-296
-66% -$48.2K ﹤0.01% 6318
2019
Q4 		$132K Buy
448
+222
+98% +$44.7K ﹤0.01% 5862
2019
Q3 		$41K Buy
226
+84
+59% +$23.9K ﹤0.01% 6385
2019
Q2 		$57K Buy
142
+27
+23% +$11.4K ﹤0.01% 6258
2019
Q1 		$54K Sell
115
-240
-68% -$117K ﹤0.01% 6166
2018
Q4 		$171K Buy
355
+246
+226% +$136K ﹤0.01% 5620
2018
Q3 		$74K Hold
109
– – ﹤0.01% 6026
2018
Q2 		$74K Buy
+109
New +$70.6K ﹤0.01% 5943

Other funds holding ELOX

SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America's ELOX Position: Q2 2023 in Review

Bank of America sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2023, closing a stake of 371 shares — an estimated $931 sold.

Bank of America first reported a position in ELOX in Q2 2018 and held it in 20 quarters. The position peaked at $171K in Q4 2018. 16 funds tracked by Wall St. Rank hold ELOX as of Q2 2023.

  • Bank of America reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Bank of America sold 371 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $931.
  • Bank of America first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 20 quarters.
  • Bank of America's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $171K in Q4 2018.
  • 16 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Bank of America's 13F filing for Q2 2023, filed 14 Aug 2023.